AJ13--Liposome Preparation for Experimental Rheumatoid Arthritis treatment
36C24526Q0665 · VETERANS AFFAIRS, DEPARTMENT OF
A PHARMACEUTICAL PREPARATION MANUFACTURING solicitation, performed in Vendor's Laboratory and/or Facility, with responses due 2026-07-31. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
SOURCES SOUGHT NOTICE Joint Targeted Drug Delivery Approach for Arthritis Therapy Liposome Preparation Department of Veterans Affairs Network Contracting Office 05 (NCO 05) 1. Purpose The Department of Veterans Affairs (VA) is conducting market research to identify qualified and experienced sources
Comparable recent awards in PHARMACEUTICAL PREPARATION MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| SRI INTERNATIONAL | $49.9M | 7 | 2026-07-02 |
| REGIMED MEDICAL | $293K | 7 | 2026-07-02 |
| UNITED THERAPEUTICS CORP | $17K | 1 | 2026-07-02 |
| THERACOM, L.L.C. | $38K | 1 | 2026-07-02 |
| PRIORITY HEALTHCARE DISTRIBUTION INC | $16K | 1 | 2026-07-02 |
Questions
What is solicitation 36C24526Q0665?
AJ13--Liposome Preparation for Experimental Rheumatoid Arthritis treatment, issued by VETERANS AFFAIRS, DEPARTMENT OF, under NAICS 325412 (PHARMACEUTICAL PREPARATION MANUFACTURING), performed in Vendor's Laboratory and/or Facility. Responses are due 2026-07-31.
What do similar contracts close for?
Comparable closed awards in this category ran from $16K to $49.9M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.